Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Change in utilization of leading traditional therapy drugs in the U.S. in 2016*
Leading specialty therapy drugs in the U.S. - utilization change 2016
This statistic shows select leading specialty therapeutic drugs' change in utilization in the United States during 2016. Harvoni (ledipasvir/sofosbuvir) for Hepatitis C had the highest increase in utilization in 2015, reaching almost a 300 percent growth in that year. In 2016, utilization decreased around 50 percent.
Change in utilization of leading traditional therapy drugs in the U.S. in 2016*
Change in utilization
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2017

Region

United States

Survey time period

2016

Supplementary notes

* Utilization trend is defined as the rate of change in total days’ supply of medication per member, across prescriptions.
The statistic includes members with commercial insurance coverage. Members used Express Scripts for retail and home delivery pharmacy services; they used Accredo, the Express Scripts specialty pharmacy, for specialty drug prescriptions.

Leading specialty therapy drugs in the U.S. - utilization change 2016
This statistic shows select leading specialty therapeutic drugs' change in utilization in the United States during 2016. Harvoni (ledipasvir/sofosbuvir) for Hepatitis C had the highest increase in utilization in 2015, reaching almost a 300 percent growth in that year. In 2016, utilization decreased around 50 percent.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Further Content: You might find this interesting as well
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.